Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €4.14 EUR
Change Today -0.04 / -0.96%
Volume 200.0
O5O On Other Exchanges
As of 1:36 PM 06/30/15 All times are local (Market data is delayed by at least 15 minutes).

oriola-kd oyj b shares (O5O) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/4/15 - €4.59
52 Week Low
09/17/14 - €2.01
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ORIOLA-KD OYJ   B SHARES (O5O)

Related News

No related news articles were found.

oriola-kd oyj b shares (O5O) Related Businessweek News

No Related Businessweek News Found

oriola-kd oyj b shares (O5O) Details

Oriola-KD Corporation operates as a pharmaceutical retail and wholesale company in Finland, Sweden, and Baltic countries. The company operates in Pharmaceutical Trade Finland and Baltics, and Pharmaceutical Trade Sweden segments. It distributes various pharmaceuticals; and provides various added value services for pharmaceutical manufacturers and pharmacies, such as distribution of clinical trials medicines and medical samples, as well as storage and distribution services for marketing materials, and other solutions. The company also sells and markets consumer health products that comprise vitamins, dietary supplements, pharmacy cosmetics, skincare products, tests, sports drinks, and wound care products. It serves primarily pharmaceutical companies and other product manufacturers, pharmacies, veterinary practices, grocery stores, health stores, hospitals, and healthcare personnel. As of December 31, 2014, the company had 304 pharmacies in Sweden. Oriola-KD Corporation is headquartered in Espoo, Finland.

2,256 Employees
Last Reported Date: 04/23/15

oriola-kd oyj b shares (O5O) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: €569.7K
Compensation as of Fiscal Year 2013.

oriola-kd oyj b shares (O5O) Key Developments

Oriola-KD Corporation Rearranges its Long-Term Revolving Credit Facility and Term Loan Agreement

Oriola-KD Corporation has agreed to rearrange its long-term revolving credit facility and term loan agreement. The signed revolving credit facility and term loan agreement approximately in total of EUR 175 million will replace the existing financing agreement that was signed on May 15, 2013. The new financing agreement consists of EUR 100 million revolving credit facility and Swedish crown denominated amortized term loan agreement approximately in total of EUR 75 million. Revolving credit facility and term loan agreement will mature in three years from the signing of the agreement.

Oriola-KD Corporation Appoints Anssi Vanjoki as Chairman and Members of the Board of Directors

Oriola-KD Corporation at its Annual General Meeting held on 30 March 2015, approved the appointment of Mr. Anssi Vanjoki as Chairman and new members of the Board of  Directors.

Oriola-KD Corporation Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Full Year of 2015

Oriola-KD Corporation reported consolidated earnings results for the first quarter ended March 31, 2015. Net sales were EUR 411.3 million against EUR 399.3 million a year ago. EBITDA was EUR 17.3 million against EUR 18.2 million a year ago. Operating profit was EUR 11.7 million against EUR 12.8 million a year ago. Profit for the period was EUR 7.4 million or EUR 0.05 per share against EUR 7.6 million or EUR 0.05 per share a year ago. Net cash flow from operating activities was EUR 13.3 million against net cash used in operating activities of EUR 25.8 million a year ago. Return on equity was 24.3% against 3.6% a year ago. At the end of March 2015, interest-bearing debt was EUR 199.9 million compared to EUR 260.5 million a year ago period. The company estimates its full-year net sales to remain at the 2014 level. Operating profit excluding non-recurring items is estimated to increase from the 2014 level. Full-year net sales for continuing operations were EUR 1,612.3 million and operating profit excluding non-recurring items was EUR 59.1 million.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
O5O:GR €4.14 EUR -0.04

O5O Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for O5O.
View Industry Companies

Industry Analysis


Industry Average

Valuation O5O Industry Range
Price/Earnings 15.0x
Price/Sales 0.4x
Price/Book 5.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORIOLA-KD OYJ B SHARES, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at